Stockhub

Laboratorios Farmaceuticos Rovi, S.A.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

3 September 2022

  • curprev 05:1605:16, 3 September 2022 95.149.241.133 talk 2,100 bytes +2,100 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent and treat venous thromboembolic disease; Enoxaparin biosimilar Becat, a low-mo..."
Retrieved from "https://stockhub.co/research/Laboratorios_Farmaceuticos_Rovi,_S.A."